Wells Fargo & Company Cytokinetics Inc Call Options Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding CYTK
# of Institutions
461Shares Held
107MCall Options Held
7.2MPut Options Held
6.2M-
Black Rock Inc. New York, NY12.4MShares$734 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$591 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.12MShares$303 Million0.22% of portfolio
-
Bank Of America Corp Charlotte, NC4.78MShares$282 Million0.03% of portfolio
-
State Street Corp Boston, MA4.52MShares$267 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.56B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...